Editorial: Targeting metabolism of cancer cells and host to overcome drug resistance: Preclinical and clinical studies

Lishun Wang; Hanchen Xu; Yadi Wu

doi:10.3389/fonc.2023.1154661

Editorial: Targeting metabolism of cancer cells and host to overcome drug resistance: Preclinical and clinical studies

Lishun Wang, Hanchen Xu, Yadi Wu

Research output: Contribution to journal › Editorial

1 Scopus citations

Original language	English
Article number	1154661
Journal	Frontiers in Oncology
Volume	13
DOIs	https://doi.org/10.3389/fonc.2023.1154661
State	Published - Feb 10 2023

Bibliographical note

Funding Information:
This work was supported in part by grants from the National Natural Science Foundation of China (81872245 to LW, 82104466 to HX) and NIH (P20GM121327 and CA230758 to YW).

Keywords

cancer metabolism
drug resistance
gut microbiome
metabolite
omics

ASJC Scopus subject areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3389/fonc.2023.1154661

Cite this

@article{498e5dbbc5af451c8fddad5ebd3cba81,

title = "Editorial: Targeting metabolism of cancer cells and host to overcome drug resistance: Preclinical and clinical studies",

keywords = "cancer metabolism, drug resistance, gut microbiome, metabolite, omics",

author = "Lishun Wang and Hanchen Xu and Yadi Wu",

note = "Funding Information: This work was supported in part by grants from the National Natural Science Foundation of China (81872245 to LW, 82104466 to HX) and NIH (P20GM121327 and CA230758 to YW). ",

year = "2023",

month = feb,

day = "10",

doi = "10.3389/fonc.2023.1154661",

language = "English",

volume = "13",

}

TY - JOUR

T1 - Editorial

T2 - Targeting metabolism of cancer cells and host to overcome drug resistance: Preclinical and clinical studies

AU - Wang, Lishun

AU - Xu, Hanchen

AU - Wu, Yadi

N1 - Funding Information: This work was supported in part by grants from the National Natural Science Foundation of China (81872245 to LW, 82104466 to HX) and NIH (P20GM121327 and CA230758 to YW).

PY - 2023/2/10

Y1 - 2023/2/10

KW - cancer metabolism

KW - drug resistance

KW - gut microbiome

KW - metabolite

KW - omics

UR - http://www.scopus.com/inward/record.url?scp=85148851286&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85148851286&partnerID=8YFLogxK

U2 - 10.3389/fonc.2023.1154661

DO - 10.3389/fonc.2023.1154661

M3 - Editorial

AN - SCOPUS:85148851286

SN - 2234-943X

VL - 13

JO - Frontiers in Oncology

JF - Frontiers in Oncology

M1 - 1154661

ER -

Editorial: Targeting metabolism of cancer cells and host to overcome drug resistance: Preclinical and clinical studies

Bibliographical note

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this